These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 38506473)
1. Incidence of amyotrophic lateral sclerosis in Chile. Lillo P; Zitko P; Godoy-Reyes G; Asenjo G; Sáez D; Cea G; Navarrete P; Valenzuela D; Hughes R; Heverin M; Logroscino G; Hardiman O Amyotroph Lateral Scler Frontotemporal Degener; 2024 Aug; 25(5-6):528-532. PubMed ID: 38506473 [TBL] [Abstract][Full Text] [Related]
2. Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009-2011 and survival characteristics through 2015. Punjani R; Wagner L; Horton K; Kaye W Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):123-130. PubMed ID: 31795746 [TBL] [Abstract][Full Text] [Related]
3. Survival and epidemiology of amyotrophic lateral sclerosis (ALS) cases in the Chicago and Detroit metropolitan cohort: incident cases 2009-2011 and survival through 2018. Punjani R; Larson TC; Wagner L; Davis B; Horton DK; Kaye W Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):203-211. PubMed ID: 36200180 [TBL] [Abstract][Full Text] [Related]
4. Amyotrophic lateral sclerosis mortality rates in Chile: A population based study (1994-2010). Valenzuela D; Zitko P; Lillo P Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(5-6):372-7. PubMed ID: 25859694 [TBL] [Abstract][Full Text] [Related]
5. LAENALS: epidemiological and clinical features of amyotrophic lateral sclerosis in Latin America. Vélez-GóMEZ B; Perna A; Vazquez C; Ketzoian C; Lillo P; Godoy-Reyes G; Sáez D; Zaldivar Vaillant T; Gutiérrez Gil JV; Lara-Fernández GE; Povedano M; Heverin M; McFarlane R; Logroscino G; Hardiman O Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):119-127. PubMed ID: 37865869 [TBL] [Abstract][Full Text] [Related]
6. Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register. Scialò C; Novi G; Bandettini di Poggio M; Canosa A; Sormani MP; Mandich P; Origone P; Truffelli R; Mancardi GL; Caponnetto C Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):535-542. PubMed ID: 27399231 [TBL] [Abstract][Full Text] [Related]
7. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model. Conde B; Winck JC; Azevedo LF Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082 [TBL] [Abstract][Full Text] [Related]
8. Prevalence, Incidence, and Clinical-Epidemiological Characterization of Amyotrophic Lateral Sclerosis in Antioquia: Colombia. Zapata-Zapata CH; Franco Dáger E; Aguirre-Acevedo DC; de Carvalho M; Solano-Atehortúa J Neuroepidemiology; 2020; 54(3):251-257. PubMed ID: 31812965 [TBL] [Abstract][Full Text] [Related]
11. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis. Byrne S; Heverin M; Elamin M; Bede P; Lynch C; Kenna K; MacLaughlin R; Walsh C; Al Chalabi A; Hardiman O Ann Neurol; 2013 Nov; 74(5):699-708. PubMed ID: 23836460 [TBL] [Abstract][Full Text] [Related]
12. Increased Incidence of Amyotrophic Lateral Sclerosis in Polymyositis: A Nationwide Cohort Study. Tseng CC; Chang SJ; Tsai WC; Ou TT; Wu CC; Sung WY; Hsieh MC; Yen JH Arthritis Care Res (Hoboken); 2017 Aug; 69(8):1231-1237. PubMed ID: 27723283 [TBL] [Abstract][Full Text] [Related]
13. Amyotrophic Lateral Sclerosis in Northern Spain 40 Years Later: What Has Changed? Riancho J; Lozano-Cuesta P; Santurtún A; Sánchez-Juan P; López-Vega JM; Berciano J; Polo JM Neurodegener Dis; 2016; 16(5-6):337-41. PubMed ID: 27188850 [TBL] [Abstract][Full Text] [Related]
14. Epidemiological time-trend of amyotrophic lateral sclerosis (ALS) over two decades: The French population-based register of ALS in Limousin (FRALim register). Luna J; Defressigne O; Erazo D; Lautrette G; Raymondeau-Moustafa M; Preux PM; Boumediene F; Couratier P Rev Neurol (Paris); 2022 Nov; 178(9):914-923. PubMed ID: 36163089 [TBL] [Abstract][Full Text] [Related]
15. Time to diagnosis in the National Registry of Veterans with Amyotrophic Lateral Sclerosis. Khishchenko N; Allen KD; Coffman CJ; Kasarskis EJ; Lindquist JH; Morgenlander JC; Norman BB; Oddone EZ; Rozear MP; Sabet A; Sams L; Bedlack RS Amyotroph Lateral Scler; 2010; 11(1-2):125-32. PubMed ID: 19153849 [TBL] [Abstract][Full Text] [Related]
16. Amyotrophic lateral sclerosis in Beijing: Epidemiologic features and prognosis from 2010 to 2015. Zhou S; Zhou Y; Qian S; Chang W; Wang L; Fan D Brain Behav; 2018 Nov; 8(11):e01131. PubMed ID: 30338660 [TBL] [Abstract][Full Text] [Related]
17. Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997-2007. Marin B; Gil J; Preux PM; Funalot B; Couratier P Amyotroph Lateral Scler; 2009 Aug; 10(4):216-20. PubMed ID: 19452307 [TBL] [Abstract][Full Text] [Related]
18. Amyotrophic lateral sclerosis in Catalonia: a population based study. Pradas J; Puig T; Rojas-García R; Viguera ML; Gich I; Logroscino G; Amyotroph Lateral Scler Frontotemporal Degener; 2013 May; 14(4):278-83. PubMed ID: 23286747 [TBL] [Abstract][Full Text] [Related]